Premium
Low dose of buprenorphine shows promising results for suicidal ideation
Publication year - 2016
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30128
Subject(s) - buprenorphine , suicidal ideation , medicine , substance abuse , psychiatry , agonist , population , opioid , emergency medicine , poison control , suicide prevention , environmental health , receptor
A very low dose of the partial opioid agonist buprenorphine over 4 weeks led to decreased suicidal ideation in a group of severely suicidal patients who did not have a substance abuse problem, a new study has found. Study authors suggest that additional research with longer follow‐up periods is needed to determine definitively whether buprenorphine is safe and effective in this population and how it should be administered. Study results were published online Dec. 18, 2015, in the American Journal of Psychiatry .